nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—ABCB1—Parkinson's disease	0.651	1	CbGaD
Mebendazole—TUBA1A—superior cervical ganglion—Parkinson's disease	0.0517	0.294	CbGeAlD
Mebendazole—TUBA1A—pons—Parkinson's disease	0.0206	0.117	CbGeAlD
Mebendazole—TUBA1A—peripheral nervous system—Parkinson's disease	0.0137	0.0777	CbGeAlD
Mebendazole—TUBA1A—nerve—Parkinson's disease	0.0107	0.0606	CbGeAlD
Mebendazole—TUBA1A—hindbrain—Parkinson's disease	0.008	0.0454	CbGeAlD
Mebendazole—TUBA1A—embryo—Parkinson's disease	0.005	0.0284	CbGeAlD
Mebendazole—TUBA1A—brainstem—Parkinson's disease	0.00458	0.026	CbGeAlD
Mebendazole—TUBA1A—forebrain—Parkinson's disease	0.00442	0.0251	CbGeAlD
Mebendazole—TUBA1A—cardiovascular system—Parkinson's disease	0.00374	0.0212	CbGeAlD
Mebendazole—TUBB4B—embryo—Parkinson's disease	0.00333	0.0189	CbGeAlD
Mebendazole—TUBA1A—medulla oblongata—Parkinson's disease	0.0032	0.0181	CbGeAlD
Mebendazole—TUBB4B—forebrain—Parkinson's disease	0.00295	0.0167	CbGeAlD
Mebendazole—TUBA1A—midbrain—Parkinson's disease	0.00292	0.0166	CbGeAlD
Mebendazole—TUBA1A—spinal cord—Parkinson's disease	0.00285	0.0162	CbGeAlD
Mebendazole—TUBA1A—head—Parkinson's disease	0.00253	0.0144	CbGeAlD
Mebendazole—TUBB4B—cardiovascular system—Parkinson's disease	0.00249	0.0141	CbGeAlD
Mebendazole—TUBA1A—nervous system—Parkinson's disease	0.0024	0.0136	CbGeAlD
Mebendazole—TUBA1A—central nervous system—Parkinson's disease	0.00231	0.0131	CbGeAlD
Mebendazole—TUBA1A—cerebellum—Parkinson's disease	0.00226	0.0128	CbGeAlD
Mebendazole—TUBB4B—medulla oblongata—Parkinson's disease	0.00213	0.0121	CbGeAlD
Mebendazole—Bopindolol—HTR1A—Parkinson's disease	0.0021	0.522	CrCbGaD
Mebendazole—TUBB4B—midbrain—Parkinson's disease	0.00195	0.011	CbGeAlD
Mebendazole—Albendazole—ABCB1—Parkinson's disease	0.00192	0.478	CrCbGaD
Mebendazole—TUBB4B—spinal cord—Parkinson's disease	0.0019	0.0108	CbGeAlD
Mebendazole—TUBA1A—brain—Parkinson's disease	0.00184	0.0104	CbGeAlD
Mebendazole—TUBB4B—head—Parkinson's disease	0.00169	0.00958	CbGeAlD
Mebendazole—TUBB4B—nervous system—Parkinson's disease	0.0016	0.00908	CbGeAlD
Mebendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00155	0.00915	CbGpPWpGaD
Mebendazole—TUBB4B—central nervous system—Parkinson's disease	0.00154	0.00874	CbGeAlD
Mebendazole—TUBB4B—cerebellum—Parkinson's disease	0.00151	0.00855	CbGeAlD
Mebendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00141	0.00837	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—ABL1—Parkinson's disease	0.00138	0.00819	CbGpPWpGaD
Mebendazole—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00132	0.00784	CbGpPWpGaD
Mebendazole—CYP1A1—Xenobiotics—CYP2D6—Parkinson's disease	0.00129	0.00766	CbGpPWpGaD
Mebendazole—TUBB4B—G2/M Transition—DCTN1—Parkinson's disease	0.00128	0.0076	CbGpPWpGaD
Mebendazole—CYP1A1—Estrogen metabolism—NQO1—Parkinson's disease	0.00127	0.00753	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—DCTN1—Parkinson's disease	0.00127	0.0075	CbGpPWpGaD
Mebendazole—CYP1A1—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00124	0.00736	CbGpPWpGaD
Mebendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA8—Parkinson's disease	0.00123	0.00728	CbGpPWpGaD
Mebendazole—TUBB4B—brain—Parkinson's disease	0.00122	0.00694	CbGeAlD
Mebendazole—CYP1A1—Xenobiotics—CYP2E1—Parkinson's disease	0.00118	0.007	CbGpPWpGaD
Mebendazole—CYP1A1—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00114	0.00674	CbGpPWpGaD
Mebendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—Parkinson's disease	0.00112	0.00663	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—ABL1—Parkinson's disease	0.00112	0.00661	CbGpPWpGaD
Mebendazole—CYP1A1—Estrogen metabolism—COMT—Parkinson's disease	0.00107	0.00631	CbGpPWpGaD
Mebendazole—CYP1A1—Tryptophan metabolism—DDC—Parkinson's disease	0.00106	0.00629	CbGpPWpGaD
Mebendazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.00102	0.00605	CbGpPWpGaD
Mebendazole—CYP1A1—Estrogen metabolism—GSTM1—Parkinson's disease	0.000975	0.00577	CbGpPWpGaD
Mebendazole—ABCB1—embryo—Parkinson's disease	0.000969	0.0055	CbGeAlD
Mebendazole—CYP1A1—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00096	0.00569	CbGpPWpGaD
Mebendazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000945	0.0056	CbGpPWpGaD
Mebendazole—CYP1A1—head—Parkinson's disease	0.000945	0.00536	CbGeAlD
Mebendazole—CYP1A1—nervous system—Parkinson's disease	0.000896	0.00509	CbGeAlD
Mebendazole—CYP1A1—Tryptophan metabolism—MAOB—Parkinson's disease	0.000893	0.00529	CbGpPWpGaD
Mebendazole—CYP1A1—central nervous system—Parkinson's disease	0.000863	0.0049	CbGeAlD
Mebendazole—ABCB1—forebrain—Parkinson's disease	0.000857	0.00487	CbGeAlD
Mebendazole—CYP1A1—Oxidative Stress—NQO1—Parkinson's disease	0.000845	0.00501	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—HSPA9—Parkinson's disease	0.000816	0.00483	CbGpPWpGaD
Mebendazole—TUBB4B—Orphan transporters—CYCS—Parkinson's disease	0.000778	0.00461	CbGpPWpGaD
Mebendazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00076	0.0045	CbGpPWpGaD
Mebendazole—ABCB1—cardiovascular system—Parkinson's disease	0.000725	0.00411	CbGeAlD
Mebendazole—CYP1A1—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000723	0.00428	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidative Stress—SOD1—Parkinson's disease	0.000722	0.00428	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidative Stress—MAOA—Parkinson's disease	0.000703	0.00417	CbGpPWpGaD
Mebendazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000696	0.00412	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidative Stress—HMOX1—Parkinson's disease	0.000695	0.00412	CbGpPWpGaD
Mebendazole—CYP1A1—brain—Parkinson's disease	0.000685	0.00389	CbGeAlD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—DCTN1—Parkinson's disease	0.000676	0.00401	CbGpPWpGaD
Mebendazole—CYP1A1—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000673	0.00399	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—LRRK2—Parkinson's disease	0.000668	0.00396	CbGpPWpGaD
Mebendazole—CYP3A4—nervous system—Parkinson's disease	0.000658	0.00373	CbGeAlD
Mebendazole—CYP1A1—Oxidative Stress—SOD2—Parkinson's disease	0.00065	0.00385	CbGpPWpGaD
Mebendazole—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000636	0.00377	CbGpPWpGaD
Mebendazole—CYP3A4—central nervous system—Parkinson's disease	0.000633	0.00359	CbGeAlD
Mebendazole—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000626	0.00371	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidative Stress—GPX1—Parkinson's disease	0.00062	0.00367	CbGpPWpGaD
Mebendazole—ABCB1—medulla oblongata—Parkinson's disease	0.000619	0.00352	CbGeAlD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000618	0.00366	CbGpPWpGaD
Mebendazole—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000612	0.00362	CbGpPWpGaD
Mebendazole—CYP1A1—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000607	0.0036	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—DCTN1—Parkinson's disease	0.000605	0.00358	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.0006	0.00356	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.0006	0.00356	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000586	0.00347	CbGpPWpGaD
Mebendazole—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000582	0.00345	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—RPL6—Parkinson's disease	0.000581	0.00344	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000568	0.00337	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000568	0.00337	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—GDNF—Parkinson's disease	0.000568	0.00336	CbGpPWpGaD
Mebendazole—ABCB1—midbrain—Parkinson's disease	0.000566	0.00321	CbGeAlD
Mebendazole—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00056	0.00331	CbGpPWpGaD
Mebendazole—ABCB1—spinal cord—Parkinson's disease	0.000552	0.00313	CbGeAlD
Mebendazole—TUBA1A—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.000551	0.00326	CbGpPWpGaD
Mebendazole—CYP1A1—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000548	0.00324	CbGpPWpGaD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000537	0.00318	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VIM—Parkinson's disease	0.000534	0.00316	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00053	0.00314	CbGpPWpGaD
Mebendazole—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000524	0.00311	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000522	0.00309	CbGpPWpGaD
Mebendazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000517	0.00306	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—DCTN1—Parkinson's disease	0.000504	0.00299	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—CP—Parkinson's disease	0.000497	0.00294	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—HSPA9—Parkinson's disease	0.000493	0.00292	CbGpPWpGaD
Mebendazole—ABCB1—head—Parkinson's disease	0.000491	0.00279	CbGeAlD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000491	0.00291	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000484	0.00287	CbGpPWpGaD
Mebendazole—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00048	0.00284	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.000473	0.0028	CbGpPWpGaD
Mebendazole—ABCB1—nervous system—Parkinson's disease	0.000465	0.00264	CbGeAlD
Mebendazole—ABCB1—central nervous system—Parkinson's disease	0.000448	0.00254	CbGeAlD
Mebendazole—TUBA1A—Metabolism of proteins—RPL23A—Parkinson's disease	0.000441	0.00261	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—RPL14—Parkinson's disease	0.000441	0.00261	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00044	0.0026	CbGpPWpGaD
Mebendazole—ABCB1—cerebellum—Parkinson's disease	0.000438	0.00249	CbGeAlD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000435	0.00258	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000412	0.00244	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—RPS8—Parkinson's disease	0.000411	0.00243	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—DCTN1—Parkinson's disease	0.000408	0.00242	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000398	0.00236	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000381	0.00225	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000372	0.0022	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—DCTN1—Parkinson's disease	0.000365	0.00216	CbGpPWpGaD
Mebendazole—ABCB1—brain—Parkinson's disease	0.000356	0.00202	CbGeAlD
Mebendazole—TUBB4B—Metabolism of proteins—RPL6—Parkinson's disease	0.000351	0.00208	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTA4—Parkinson's disease	0.000349	0.00207	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000344	0.00204	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.000333	0.00197	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000327	0.00194	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—CTGF—Parkinson's disease	0.000324	0.00192	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—Parkinson's disease	0.000318	0.00188	CbGpPWpGaD
Mebendazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000312	0.00185	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—MAOB—Parkinson's disease	0.000311	0.00184	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—DCTN1—Parkinson's disease	0.000304	0.0018	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000302	0.00179	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000299	0.00177	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000297	0.00176	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000296	0.00175	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000288	0.00171	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000279	0.00165	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000277	0.00164	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—RPL14—Parkinson's disease	0.000266	0.00158	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—RPL23A—Parkinson's disease	0.000266	0.00158	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000264	0.00156	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000261	0.00154	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00025	0.00148	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—RPS8—Parkinson's disease	0.000248	0.00147	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—IGF2—Parkinson's disease	0.000245	0.00145	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000242	0.00143	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000241	0.00143	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000238	0.00141	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP2D6—Parkinson's disease	0.000231	0.00137	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000228	0.00135	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000222	0.00131	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—Parkinson's disease	0.000219	0.0013	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000214	0.00127	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP2E1—Parkinson's disease	0.000211	0.00125	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000209	0.00124	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000207	0.00123	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000198	0.00117	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000196	0.00116	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000193	0.00115	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00019	0.00112	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—COMT—Parkinson's disease	0.000175	0.00104	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000175	0.00104	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000175	0.00104	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTP1—Parkinson's disease	0.000174	0.00103	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—MAOA—Parkinson's disease	0.000174	0.00103	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—COMT—Parkinson's disease	0.000173	0.00102	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000173	0.00102	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000173	0.00102	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000172	0.00102	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000172	0.00102	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000169	0.001	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000165	0.000978	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—INS—Parkinson's disease	0.000163	0.000963	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000161	0.000955	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTM1—Parkinson's disease	0.00016	0.000949	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000158	0.000938	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000158	0.000936	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000153	0.000907	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGF2—Parkinson's disease	0.000148	0.000876	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000125	0.000741	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	0.000125	0.000741	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	0.000125	0.000739	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000123	0.00073	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000121	0.000715	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000114	0.000674	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ND3—Parkinson's disease	0.000114	0.000673	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MCCC1—Parkinson's disease	0.000114	0.000673	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000112	0.000665	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000109	0.000648	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TALDO1—Parkinson's disease	0.000107	0.000633	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—OMD—Parkinson's disease	0.000107	0.000633	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000104	0.000616	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000103	0.000608	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NDUFB11—Parkinson's disease	0.000101	0.0006	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—INS—Parkinson's disease	9.82e-05	0.000582	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GCH1—Parkinson's disease	9.66e-05	0.000572	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	9.16e-05	0.000543	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—Parkinson's disease	9.08e-05	0.000538	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MCCC1—Parkinson's disease	9.07e-05	0.000537	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ND3—Parkinson's disease	9.07e-05	0.000537	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	8.71e-05	0.000516	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—COMT—Parkinson's disease	8.62e-05	0.000511	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—FBP1—Parkinson's disease	8.61e-05	0.00051	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—DBH—Parkinson's disease	8.61e-05	0.00051	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GBA—Parkinson's disease	8.61e-05	0.00051	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	8.58e-05	0.000508	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	8.56e-05	0.000507	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—OMD—Parkinson's disease	8.53e-05	0.000505	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TALDO1—Parkinson's disease	8.53e-05	0.000505	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	8.5e-05	0.000504	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	8.46e-05	0.000501	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	8.43e-05	0.0005	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NDUFB11—Parkinson's disease	8.09e-05	0.000479	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	7.88e-05	0.000467	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	7.78e-05	0.000461	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GCH1—Parkinson's disease	7.72e-05	0.000457	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GBA—Parkinson's disease	6.88e-05	0.000407	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—FBP1—Parkinson's disease	6.88e-05	0.000407	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—DBH—Parkinson's disease	6.88e-05	0.000407	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—DDC—Parkinson's disease	6.32e-05	0.000374	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	6.16e-05	0.000365	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	6.01e-05	0.000356	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTA4—Parkinson's disease	5.97e-05	0.000353	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.89e-05	0.000349	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.77e-05	0.000342	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	5.66e-05	0.000335	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MCCC1—Parkinson's disease	5.59e-05	0.000331	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ND3—Parkinson's disease	5.59e-05	0.000331	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	5.37e-05	0.000318	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MAOB—Parkinson's disease	5.32e-05	0.000315	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—OMD—Parkinson's disease	5.26e-05	0.000311	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TALDO1—Parkinson's disease	5.26e-05	0.000311	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.06e-05	0.0003	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—DDC—Parkinson's disease	5.05e-05	0.000299	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	5.01e-05	0.000297	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	4.98e-05	0.000295	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA4—Parkinson's disease	4.77e-05	0.000282	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GCH1—Parkinson's disease	4.75e-05	0.000282	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.48e-05	0.000265	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PLA2G6—Parkinson's disease	4.29e-05	0.000254	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MAOB—Parkinson's disease	4.25e-05	0.000252	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GBA—Parkinson's disease	4.24e-05	0.000251	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—DBH—Parkinson's disease	4.24e-05	0.000251	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—FBP1—Parkinson's disease	4.24e-05	0.000251	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	3.95e-05	0.000234	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CTGF—Parkinson's disease	3.88e-05	0.00023	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	3.62e-05	0.000214	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NQO1—Parkinson's disease	3.57e-05	0.000212	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TH—Parkinson's disease	3.52e-05	0.000209	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYCS—Parkinson's disease	3.38e-05	0.0002	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2D6—Parkinson's disease	3.16e-05	0.000187	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—DDC—Parkinson's disease	3.11e-05	0.000184	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CTGF—Parkinson's disease	3.1e-05	0.000184	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—COMT—Parkinson's disease	3e-05	0.000177	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTP1—Parkinson's disease	2.98e-05	0.000177	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MAOA—Parkinson's disease	2.97e-05	0.000176	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HMOX1—Parkinson's disease	2.94e-05	0.000174	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.94e-05	0.000174	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.89e-05	0.000171	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NQO1—Parkinson's disease	2.86e-05	0.000169	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCB1—Parkinson's disease	2.82e-05	0.000167	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TH—Parkinson's disease	2.81e-05	0.000167	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTM1—Parkinson's disease	2.74e-05	0.000162	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYCS—Parkinson's disease	2.7e-05	0.00016	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.64e-05	0.000157	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GPX1—Parkinson's disease	2.62e-05	0.000155	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.62e-05	0.000155	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—Parkinson's disease	2.42e-05	0.000143	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—COMT—Parkinson's disease	2.39e-05	0.000142	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.38e-05	0.000141	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MAOA—Parkinson's disease	2.38e-05	0.000141	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.35e-05	0.000139	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—APOE—Parkinson's disease	2.25e-05	0.000134	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.19e-05	0.00013	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GPX1—Parkinson's disease	2.1e-05	0.000124	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.95e-05	0.000115	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.93e-05	0.000115	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—INS—Parkinson's disease	1.93e-05	0.000114	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.91e-05	0.000113	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—APOE—Parkinson's disease	1.8e-05	0.000107	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.78e-05	0.000105	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.76e-05	0.000104	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TH—Parkinson's disease	1.73e-05	0.000103	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.66e-05	9.86e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—INS—Parkinson's disease	1.54e-05	9.11e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—COMT—Parkinson's disease	1.47e-05	8.73e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.47e-05	8.69e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.46e-05	8.67e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.45e-05	8.57e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.39e-05	8.23e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.35e-05	7.99e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.29e-05	7.65e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.19e-05	7.06e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—APOE—Parkinson's disease	1.11e-05	6.57e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—INS—Parkinson's disease	9.48e-06	5.61e-05	CbGpPWpGaD
